The Patterson Perspective

Kasm Technologies and F5 are uniting to redefine secure remote access, blending containerized VDI with advanced security for the modern enterprise.

Securities finance giant EquiLend's strategic investment in Digital Prime signals a major move to build institutional-grade infrastructure for tokenized assets.

SCALE AI's record funding fuels 44 new projects, aiming to accelerate homegrown AI and secure Canada's digital future amid fierce global competition.

As gold, silver, and platinum hit historic highs, Deutsche Bank is issuing new securities for its physically-backed Xtrackers products to meet demand.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.

EfTEN United Property Fund's soaring profits, fueled by a key housing project, highlight a strategic success story amid a recovering Baltic property market.

A major tech conference highlights a critical global skills gap in AI and security. Is Canadian policy ready for the infrastructure of tomorrow?

A landmark defense contract for 100,000 night-vision devices in Europe signals a major leap in military tech and raises the bar for NATO interoperability.

Enverus unveils an 'AI operating system' for energy, promising a 10x productivity boost. But what does this mean for the industry's security and future?

As community hubs face new threats, advanced AI surveillance offers powerful protection. But what are the costs and ethical lines for Canadian organizations?

A German tech firm's new platform offers a real-time map of grid capacity, aiming to solve a critical hurdle in North America's energy transition.

The fashion giant beat earnings and initiated a dividend, but declining sales and consumer uncertainty reveal a complex picture for the apparel industry.

A landmark $275M deal for a novel Hunter syndrome drug highlights a new frontier in treating brain diseases and a major shift in biotech funding.

A new FDA-approved drug, EMPAVELI, shows unprecedented results for two rare kidney diseases, offering hope to patients facing dialysis or transplant.

A new social media dictionary reveals the words that defined 2025, but its predictions for 2026 signal a growing battle between human authenticity and AI.

Akebia Therapeutics expands its pipeline, targeting rare kidney diseases with two novel drugs and offering new hope where treatment options are scarce.

Shipping giant Hafnia declares a robust Q3 dividend, backed by strong earnings and a bullish market outlook. Here’s what it means for investors.

With massive funding and a coordinated national strategy, a Chinese city is luring elite innovators. What can Canada learn from its aggressive talent hunt?

A nearly $1 million deal for AI-powered smart glasses is rolling out in Canada, signaling a major shift in warehouse work and supply chain efficiency.

Novartis's $560K Health Equity Initiative funds grassroots projects, highlighting a strategic shift in tackling Canada's deep-seated health disparities.